Protein profiling as a diagnostic tool in clinical chemistry: a review

被引:35
作者
Bons, JAP [1 ]
Wodzig, WKWH [1 ]
van Dieijen-Visser, MP [1 ]
机构
[1] Univ Hosp Maastricht, Dept Clin Chem, NL-6229 HX Maastricht, Netherlands
关键词
biomarker; decision tree; diagnostic value; ovarian cancer; post-analytical conditions; pre-analytical conditions; prostate cancer; protein profiling; proteomics; surface-enhanced laser desorption/ionization time-of-flight mass spectrometry;
D O I
10.1515/CCLM.2005.222
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry (SELDI-TOF MS) appears to be an important diagnostic tool for a whole range of diseases. Sensitivities and specificities obtained with this new technology often seem superior to those obtained with current biomarkers. However, reproducibility and standardization are still problematic. The present review gives an overview of the diagnostic value of protein profiles obtained with SELDI in studies on prostate and ovarian cancer. To identify aspects important for protein profiling, we compare and discuss differences in pre- and post-analytical conditions presented in the literature supplemented with some of our own data. Further progress in protein profiling as a diagnostic tool requires a more comprehensive description of technical details in all future studies.
引用
收藏
页码:1281 / 1290
页数:10
相关论文
共 31 条
[1]  
Adam BL, 2002, CANCER RES, V62, P3609
[2]  
BAGGERLY KA, 2003, CAUTIONS REPROD MASS
[3]   Diagnostic potential of serum proteomic patterns in prostate cancer [J].
Bañez, LL ;
Prasanna, P ;
Sun, L ;
Ali, A ;
Zou, ZQ ;
Adam, BL ;
McLeod, DG ;
Moul, JW ;
Srivastava, S .
JOURNAL OF UROLOGY, 2003, 170 (02) :442-446
[4]   The effect of class-specific protease inhibitors on the stabilization of B-type natriuretic peptide in human plasma [J].
Belenky, A ;
Smith, A ;
Zhang, B ;
Lin, S ;
Despres, N ;
Wu, AHB ;
Bluestein, BI .
CLINICA CHIMICA ACTA, 2004, 340 (1-2) :163-172
[5]   How are we going to discover new cancer biomarkers? A proteomic approach for bladder cancer [J].
Diamandis, EP .
CLINICAL CHEMISTRY, 2004, 50 (05) :793-795
[6]   NEW DESORPTION STRATEGIES FOR THE MASS-SPECTROMETRIC ANALYSIS OF MACROMOLECULES [J].
HUTCHENS, TW ;
YIP, TT .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 1993, 7 (07) :576-580
[7]   Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis [J].
Kozak, KR ;
Amneus, MW ;
Pusey, SM ;
Su, F ;
Luong, MN ;
Luong, SA ;
Reddy, ST ;
Farias-Eisner, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (21) :12343-12348
[8]   Revealing urologic diseases by proteomic techniques [J].
Lee, SW ;
Lee, KI ;
Kim, JY .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 815 (1-2) :203-213
[9]   Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population [J].
Li, JN ;
White, N ;
Zhang, Z ;
Rosenzweig, J ;
Mangold, LA ;
Partin, AW ;
Chan, DW .
JOURNAL OF UROLOGY, 2004, 171 (05) :1782-1787
[10]   Profiling of rat plasma by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry, a novel tool for biomarker discovery in nutrition research [J].
Linke, T ;
Ross, AC ;
Harrison, EH .
JOURNAL OF CHROMATOGRAPHY A, 2004, 1043 (01) :65-71